SEZARY SYNDROME
Clinical trials for SEZARY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SEZARY SYNDROME trials appear
Sign up with your email to follow new studies for SEZARY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare skin cancer: light therapy targets tumor cells
Disease control Recruiting nowThis study tests a treatment called extracorporeal photopheresis (ECP) for people with Sezary syndrome, a rare type of skin lymphoma. The goal is to see if ECP can reduce the number of cancer cells in the blood. Twenty participants will receive weekly ECP for a month, then every …
Matched conditions: SEZARY SYNDROME
Sponsor: Oleg E. Akilov, MD, PhD • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
New combo therapy offers hope for rare skin cancer patients
Disease control Recruiting nowThis study tests a new combination treatment for a rare type of skin lymphoma called erythrodermic cutaneous T-cell lymphoma (CTCL). The treatment combines a light-based blood therapy (ECP) with a targeted antibody drug (mogamulizumab) to kill cancer cells and boost the immune sy…
Matched conditions: SEZARY SYNDROME
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New drug monitored for rare skin cancer patients
Disease control Recruiting nowThis study watches how safe and effective the drug mogamulizumab is for adults with mycosis fungoides or Sezary syndrome, two rare types of skin lymphoma. About 15 people will be followed during their normal treatment to track side effects and how well the drug controls the disea…
Matched conditions: SEZARY SYNDROME
Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Could a lower dose of this cancer drug be just as effective?
Disease control Recruiting nowThis study is testing a lower dose of the drug brentuximab vedotin in people with mycosis fungoides, Sezary syndrome, or lymphomatoid papulosis—types of lymphoma that affect the skin. The goal is to see if the lower dose works as well as the standard dose but with fewer side effe…
Matched conditions: SEZARY SYNDROME
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Scientists collect samples to unlock secrets of skin diseases
Knowledge-focused Recruiting nowThis study collects blood, urine, and skin samples from 200 adults with cutaneous T-cell lymphoma, eczema, or atopic dermatitis. The samples are stored for current and future research to better understand these conditions. Participants must be 18 or older and have a confirmed dia…
Matched conditions: SEZARY SYNDROME
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated May 26, 2026 08:38 UTC
-
Massive T-Cell lymphoma database aims to unlock better treatments
Knowledge-focused Recruiting nowThis study is creating a large database of information from 1,000 people with T-cell lymphoma. Researchers will collect medical records and tumor samples to learn more about the disease and how to improve care. No new treatments are being tested; the goal is to gather data for fu…
Matched conditions: SEZARY SYNDROME
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC